Skip to main content

Prisoner, Denied Treatment, Dies Of Cancer in Israeli Prison

Daoud Kuttab interviews Tariq Abu Hamdia, son of Maysara Abu Hamdia, who died April 2 in an Israeli prison despite appeals for him to be released for cancer treatment, which he never received.
A Hamas militant holds a poster of Maysara Abu Hamdeya before a protest in the northern Gaza Strip April 2, 2013. Israeli prison guards fired tear gas to quell disturbances by Palestinian inmates on Tuesday after a prisoner serving a life sentence over an attempt to bomb an Israeli cafe died of cancer. Maysara Abu Hamdeya's death threatened to raise tensions in the Israeli-occupied West Bank, where Palestinians, who view jailed brethren as heroes in a fight for statehood, have held several protests in recen

When President Barack Obama visited Bethlehem, the loudest group of protesters were families of Palestinian prisoners, many of whom have husbands and sons locked up in Israeli jails. Some of the families were demanding that the Israelis honor promises made to release those held from before the Oslo agreements, other families complained that they have not been allowed to meet their loved ones for years. Yet, a third group said sick prisoners were not receiving appropriate medical care. According to the son of Maysara Abu Hamdia, who died Tuesday [April 2] after his cancer went untreated, that is exactly what happened.

Maysara Abu Hamdia, 64, was a colonel with the Palestinian Preventive Security Service in 2002 when he was arrested and charged with multiple offenses, mostly assisting Hamas operatives. According to Tariq Abu Hamdia, the prisoner’s oldest son, the Israelis had nothing on his father. They couldn’t extract a confession and had no serious evidence,” he said in a phone interview from Virginia Tech where he is finishing his Ph.D. in mechanical engineering.

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.

Subscribe

Only $100 per year.